Keith A. Goldan Syndax Pharmaceuticals Inc (SNDX) insider trading activity

SNDX Quotes by TradingView

Keith A. Goldan is Chief Financial Officer of Syndax Pharmaceuticals Inc. Currently has a direct ownership of 52,623 shares of SNDX, which is worth approximately $992,469. The most recent transaction as insider was on Jun 14, 2024, when has been sold 1,250 shares (Common Stock) at a price of $20.03 per share, resulting in proceeds of $25,037. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 52.6K
0% 3M change
1407.82% 12M change
Total Value Held $992,469

Keith A. Goldan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 14 2024
BUY
Open market or private purchase
$25,037 $20.03 p/Share
1,250 Added 2.32%
52,623 Common Stock
Feb 07 2024
BUY
Grant, award, or other acquisition
-
46,700 Added 47.62%
51,373 Common Stock
Jan 31 2024
BUY
Other acquisition or disposition
$20,607 $17.42 p/Share
1,183 Added 20.2%
4,673 Common Stock
Jul 31 2023
BUY
Other acquisition or disposition
$15,619 $18.12 p/Share
862 Added 19.81%
3,490 Common Stock
Jun 13 2023
SELL
Open market or private sale
$12,872 $22.31 p/Share
577 Reduced 18.0%
2,628 Common Stock
Jun 13 2022
BUY
Grant, award, or other acquisition
-
3,205 Added 50.0%
3,205 Common Stock

Also insider at

OPTN
OptiNose, Inc. Healthcare
Chief Financial Officer
KAG

Keith A. Goldan

Chief Financial Officer
Waltham, MA

Track Institutional and Insider Activities on SNDX

Follow Syndax Pharmaceuticals Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SNDX shares.

Notify only if

Insider Trading

Get notified when an Syndax Pharmaceuticals Inc insider buys or sells SNDX shares.

Notify only if

News

Receive news related to Syndax Pharmaceuticals Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SNDX